相关实验视频
Updated: Feb 25, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
伊托普里德对功能性消化不良症状进展的影响:一个多中心的非干预性注册后研究
Jiri Dolina1, Jan Tack2, Serhiy Forostyak3
1Department of Gastroenterology and Internal Medicine, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, 625 00, Czech Republic.
在一项为期12周的研究中,伊托普里德化物有效地减少了功能性消化不良 (FD) 症状. 这种 prokinetic 剂在 339 名患者中显示出显著的症状改善与最小的不良反应.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 功能性消化不良 (FD) 是一种常见的胃肠道疾病.
- 吃完饭后的腹和腹上疼痛等FD症状会影响生活质量.
研究的目的:
- 为了评估伊托普里德化在缓解FD症状方面的疗效.
- 评估伊托普里德化在FD患者中的安全性.
主要方法:
- 一项为期12周的前性多中心观察性研究,涉及339名FD患者.
- 在基线和随访时,使用修改的卢文食后痛苦量表来测量症状的严重程度.
- 统计分析包括威尔科克森,曼-惠特尼和克鲁斯卡尔-瓦利斯测试.
主要成果:
- 伊托普里德化物显著降低了FD症状严重性得分,在3-6周减少了5分,在7-12周减少了8分.
- 在所有患者亚组中,无论年龄和性别,都观察到症状改善.
- 只有2%的患者报告了轻微的不良反应,这表明了有利的安全性.
结论:
- 伊托普里德化物是一种安全有效的治疗方法,用于控制功能性消化不良症状.
- 该研究支持itopride在临床实践中用于FD管理的使用.
- 这些发现有助于了解伊托普里德在东欧人口中的长期益处和安全性.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
